Hanke lühikirjeldus
The Norwegian Institute of Public Health (NIPH) (hereinafter referred to as the “Customer”) intends to procure a multiplex protein detection system with dual-reporter fluorescence for immunological analyses, specifically for the simultaneous detection of multiple antibody isotypes and specificities within a single sample.
This investment aims to strengthen laboratory capacity in the areas of surveillance, preparedness, research, and the national vaccination program.
The procurement includes a multiplex detection instrument along with accompanying software, installation, training kits, warranty, and long-term service and maintenance. A framework agreement for the future purchase of system-specific consumables and post-warranty maintenance services is also required. See appendix 4 chapter 2 for further information.
The instrument must support high-throughput immunological analyses with dual-reporter fluorescence. It should be compatible with existing Luminex/Bio-Rad-based workflows (e.g., Bio-Plex Manager 6.2) or similar solutions. This strategic investment is expected to improve operational efficiency, data integrity, and scientific output.